enzyme Archives - My Pharmacy News

09/29/2021

Long-held theory of cancer-induced immune suppression requires revision, study says

Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism

04/20/2021

Can an immunosuppressive cancer drug promote SARS-CoV-2 entry into host cells?

A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and

04/16/2021

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka

03/22/2021

Male fertility and androgen production may be impacted by COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The

03/16/2021

The role of RNA capping of SARS-CoV-2 in immunity evasion

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen successfully uses multiple immune evasion mechanisms to achieve infection within its

02/24/2021

Basigin does not facilitate SARS-CoV-2 entry, say researchers

A study recently conducted at the Jenner Institute, University of Oxford, UK, has investigated the significance of a transmembrane glycoprotein

02/08/2021

Scientists produce active antigen in bacteria to help combat SARS-CoV-2

Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic has placed a significant

02/01/2021

Ramace

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAMACE® Ramipril Consumer Medicine Information What is

01/31/2021

Codapane Forte 500/30mg

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CODAPANE FORTE Consumer Medicine Information (CMI) summary

01/31/2021

Imatinib-Teva

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IMATINIB-TEVA® CMI VERSION 2.0 Imatinib (as mesilate)